2021 Allogeneic haematopoietic cell transplantation for myelofibrosis: proposed definitions and management strategies for graft failure, poor graft function and relapse: best practice recommendations of the EBMT Chronic Malignancies Working Party Group Chronic Malignancies Working Party (CMWP) 1st listed author Donal P McLornan Journal Leukemia.
2021 Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Nicolaus Kröger Journal Leukemia.
2020 Allogeneic Transplantation in Multiple Myeloma-Does It Still Have a Place? Group Chronic Malignancies Working Party (CMWP) 1st listed author Gösta Gahrton Journal J Clin Med.
2020 European wide survey on allogeneic haematopoietic cell transplantation practice for myelofibrosis on behalf of the EBMT chronic malignancies working party Group Chronic Malignancies Working Party (CMWP) 1st listed author Donal P McLornan Journal Curr Res Transl Med.
2020 Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study Group Chronic Malignancies Working Party (CMWP) 1st listed author Johannes Schetelig Journal Bone Marrow Transplant.
2020 Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT) Group Chronic Malignancies Working Party (CMWP) 1st listed author Nicola Polverelli Journal Am J Hematol.
2020 Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Donal P McLornan Journal Br J Haematol.
2020 Upfront stem cell transplantation for newly diagnosed multiple myeloma with del(17p) and t(4;14): a study from the CMWP-EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Nico Gagelmann Journal Bone Marrow Transplant.
2020 Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes in myeloma patients on renal replacement therapy: a report from the Chronic Malignancy Working Party (CMWP) of the European Society of Blood and Marrow Transplantation (EBMT) Group Chronic Malignancies Working Party (CMWP) 1st listed author Meral Beksac Journal Bone Marrow Transplant.
2020 Are Autologous Stem Cell Transplants Still Required to Treat Myeloma in the Era of Novel Therapies? A Review from the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Laurent Garderet Journal Biol Blood Marrow Transplant.
2020 Treosulfan conditioning for allogeneic transplantation in multiple myeloma - improved overall survival in first line haematopoietic stem cell transplantation - a large retrospective study by the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Charlotte Gran Journal Br J Haematol.
2020 Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party Group Chronic Malignancies Working Party (CMWP) 1st listed author Johannes Schetelig Journal Bone Marrow Transplant.